In the high-stakes game of gene therapy, adeno-associated virus (AAV) vectors have been the go-to workhorses. These vectors have the ability to deliver a therapeutic gene to a patient’s cells, offering hope for the treatment of genetic disorders, such as Duchenne muscular dystrophy, hemophilia A, and certain retinal degeneration disorders. But, akin to a mail […]
Tag: oncogene
Unlocking New Cancer Therapeutics: Boundless Bio CEO at Healthcare Conference
In the relentless pursuit of transforming cancer therapeutics, Boundless Bio, a clinical-stage oncology company, is making waves with its groundbreaking research in extrachromosomal DNA (ecDNA). This San Diego-based biotech startup is dedicating its resources to address a critical unmet need in the oncology landscape – tackling the challenge of oncogene amplified tumors. Boundless Bio has […]